Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom van der Poll

Showing results (421-430 of 774) with videos related to

Pageof 78
Sort By:
Molecular Medicine (Cambridge, Mass.)|August 11, 2016
Toll-like receptor 9 enhances bacterial clearance and limits lung consolidation in murine pneumonia caused by methicillin resistant <i>Staphylococcus aureus</i>Anne Jan van der Meer, Achmed Achouiti, Arie van der Ende, et al.
Immunobiology|July 31, 2018
MRP8/14 does not contribute to dissemination or inflammation in a murine model of Lyme borreliosisLauren M K Mason, Jeroen Coumou, Jasmin I Ersöz, et al.
RMD Open|May 18, 2021
Long-term safety and effectiveness of canakinumab therapy in patients with cryopyrin-associated periodic syndrome: results from the β-Confident RegistryUlrich A Walker, Hugh H Tilson, Philip N Hawkins, et al.
Antimicrobial Agents and Chemotherapy|August 16, 2022
The Azithromycin Pro-Drug CSY5669 Boosts Bacterial Killing While Attenuating Lung Inflammation Associated with Pneumonia Caused by Methicillin-Resistant Staphylococcus aureusAnno Saris, Wanhai Qin, Christine C A van Linge, et al.
Plos One|May 21, 2015
Feasibility and Safety of Local Treatment with Recombinant Human Tissue Factor Pathway Inhibitor in a Rat Model of Streptococcus pneumoniae PneumoniaFlorry E van den Boogaard, Jorrit J Hofstra, Cornelis van 't Veer, et al.
Blood|April 19, 2003
Plasminogen activator inhibitor type-1 deficiency does not influence the outcome of murine pneumococcal pneumoniaAnita W Rijneveld, Sandrine Florquin, Paul Bresser, et al.
Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)|February 23, 2016
An Ixodes ricinus Tick Salivary Lectin Pathway Inhibitor Protects Borrelia burgdorferi sensu lato from Human ComplementAlex Wagemakers, Jeroen Coumou, Tim J Schuijt, et al.
British Journal of Haematology|March 13, 2016
Impact of HIV infection on the haemostatic response during sepsis and malariaMichaëla A M Huson, Rachel Kalkman, Arie J Hoogendijk, et al.
Microbiology Spectrum|July 28, 2021
Tenascin C Has a Modest Protective Effect on Acute Lung Pathology during Methicillin-Resistant Staphylococcus aureus-Induced Pneumonia in MiceMariska T Meijer, Alex F de Vos, Hessel Peters Sengers, et al.
The Journal of Infectious Diseases|June 8, 2004
Inhibition of the tissue factor/factor VIIa pathway does not influence the inflammatory or antibacterial response to abdominal sepsis induced by Escherichia coli in miceSebastian Weijer, Saskia H H F Schoenmakers, Sandrine Florquin, et al.
Pageof 78

Showing results (421-430 of 774) with videos related to

Sort By:
Pageof 78
Molecular Medicine (Cambridge, Mass.)|August 11, 2016
Toll-like receptor 9 enhances bacterial clearance and limits lung consolidation in murine pneumonia caused by methicillin resistant <i>Staphylococcus aureus</i>Anne Jan van der Meer, Achmed Achouiti, Arie van der Ende, et al.
Immunobiology|July 31, 2018
MRP8/14 does not contribute to dissemination or inflammation in a murine model of Lyme borreliosisLauren M K Mason, Jeroen Coumou, Jasmin I Ersöz, et al.
RMD Open|May 18, 2021
Long-term safety and effectiveness of canakinumab therapy in patients with cryopyrin-associated periodic syndrome: results from the β-Confident RegistryUlrich A Walker, Hugh H Tilson, Philip N Hawkins, et al.
Antimicrobial Agents and Chemotherapy|August 16, 2022
The Azithromycin Pro-Drug CSY5669 Boosts Bacterial Killing While Attenuating Lung Inflammation Associated with Pneumonia Caused by Methicillin-Resistant Staphylococcus aureusAnno Saris, Wanhai Qin, Christine C A van Linge, et al.
Plos One|May 21, 2015
Feasibility and Safety of Local Treatment with Recombinant Human Tissue Factor Pathway Inhibitor in a Rat Model of Streptococcus pneumoniae PneumoniaFlorry E van den Boogaard, Jorrit J Hofstra, Cornelis van 't Veer, et al.
Blood|April 19, 2003
Plasminogen activator inhibitor type-1 deficiency does not influence the outcome of murine pneumococcal pneumoniaAnita W Rijneveld, Sandrine Florquin, Paul Bresser, et al.
Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)|February 23, 2016
An Ixodes ricinus Tick Salivary Lectin Pathway Inhibitor Protects Borrelia burgdorferi sensu lato from Human ComplementAlex Wagemakers, Jeroen Coumou, Tim J Schuijt, et al.
British Journal of Haematology|March 13, 2016
Impact of HIV infection on the haemostatic response during sepsis and malariaMichaëla A M Huson, Rachel Kalkman, Arie J Hoogendijk, et al.
Microbiology Spectrum|July 28, 2021
Tenascin C Has a Modest Protective Effect on Acute Lung Pathology during Methicillin-Resistant Staphylococcus aureus-Induced Pneumonia in MiceMariska T Meijer, Alex F de Vos, Hessel Peters Sengers, et al.
The Journal of Infectious Diseases|June 8, 2004
Inhibition of the tissue factor/factor VIIa pathway does not influence the inflammatory or antibacterial response to abdominal sepsis induced by Escherichia coli in miceSebastian Weijer, Saskia H H F Schoenmakers, Sandrine Florquin, et al.
Pageof 78